antigen receptor (CAR) T cell therapy

FDA approves first cell-based gene therapy for adult patients with relapsed or refractory MCL

Tecartus, a chimeric antigen receptor (CAR) T cell therapy, is the first cell-based gene therapy approved by the FDA for the…